161 related articles for article (PubMed ID: 21069156)
1. Metalloproteins and neuronal death.
Brown DR
Metallomics; 2010 Mar; 2(3):186-94. PubMed ID: 21069156
[TBL] [Abstract][Full Text] [Related]
2. Brain proteins that mind metals: a neurodegenerative perspective.
Brown DR
Dalton Trans; 2009 Jun; (21):4069-76. PubMed ID: 19452053
[TBL] [Abstract][Full Text] [Related]
3. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
4. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia.
Trojanowski JQ; Goedert M; Iwatsubo T; Lee VM
Cell Death Differ; 1998 Oct; 5(10):832-7. PubMed ID: 10203692
[TBL] [Abstract][Full Text] [Related]
5. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
[TBL] [Abstract][Full Text] [Related]
6. Metal attenuating therapies in neurodegenerative disease.
Mot AI; Wedd AG; Sinclair L; Brown DR; Collins SJ; Brazier MW
Expert Rev Neurother; 2011 Dec; 11(12):1717-45. PubMed ID: 22091597
[TBL] [Abstract][Full Text] [Related]
7. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
Gallardo G; Schlüter OM; Südhof TC
Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and neurotoxicity.
Sayre LM; Perry G; Smith MA
Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
Uversky VN
J Neurochem; 2007 Oct; 103(1):17-37. PubMed ID: 17623039
[TBL] [Abstract][Full Text] [Related]
10. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
11. Heredity in Parkinson's disease: new findings.
Lev N; Melamed E
Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
[TBL] [Abstract][Full Text] [Related]
12. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
Armstrong RA; Lantos PL; Cairns NJ
Neuropathology; 2008 Aug; 28(4):351-65. PubMed ID: 18433435
[TBL] [Abstract][Full Text] [Related]
13. The role of alpha-synuclein in neurodegenerative diseases.
Bennett MC
Pharmacol Ther; 2005 Mar; 105(3):311-31. PubMed ID: 15737408
[TBL] [Abstract][Full Text] [Related]
14. Iron in neuronal function and dysfunction.
Salvador GA
Biofactors; 2010; 36(2):103-10. PubMed ID: 20232345
[TBL] [Abstract][Full Text] [Related]
15. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol involvement in the pathogenesis of neurodegenerative diseases.
Liu JP; Tang Y; Zhou S; Toh BH; McLean C; Li H
Mol Cell Neurosci; 2010 Jan; 43(1):33-42. PubMed ID: 19660552
[TBL] [Abstract][Full Text] [Related]
17. Neurons and mechanisms of neuronal death in neurodegenerative diseases: a brief review.
Waggie KS; Kahle PJ; Tolwani RJ
Lab Anim Sci; 1999 Aug; 49(4):358-62. PubMed ID: 10480639
[TBL] [Abstract][Full Text] [Related]
18. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration.
Hirabayashi M; Inoue K; Tanaka K; Nakadate K; Ohsawa Y; Kamei Y; Popiel AH; Sinohara A; Iwamatsu A; Kimura Y; Uchiyama Y; Hori S; Kakizuka A
Cell Death Differ; 2001 Oct; 8(10):977-84. PubMed ID: 11598795
[TBL] [Abstract][Full Text] [Related]
19. Oligomeric alpha-synuclein and its role in neuronal death.
Brown DR
IUBMB Life; 2010 May; 62(5):334-9. PubMed ID: 20209636
[TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
